PluroGen Therapeutics
Charlottesville, Virginia, United States
About PluroGen Therapeutics
PluroGen's core technology platform was developed by researchers and physicians in University of Virginia's (UVA) Plastic Surgery Research Laboratory beginning in the 1970's. Their co-founder, George T. Rodeheaver, Ph.D., is one of the inventors of this technology and has supervised the formulation and production at UVA of one of their first products for use on burn and chronic wound patients at the UVA Health System for the past fifteen years.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.7M
- Last round: Series Unknown (Apr 2014)
- Website: wardenbio.comindex.html
- Phone: +1 443-994-0101
Industries & Categories
Health Care, Manufacturing, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/plurogen-therapeutics-2460095 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.